Venus Medtech (Hangzhou) Inc.

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2022🗂️ Report periods on file: 2022, 2019

In its 2022 reporting, Venus Medtech (Hangzhou) Inc. disclosed greenhouse gas emissions of 4.4K tCO2e/year (Scope 1 and 2). By scope: Scope 1: 70.21 tCO2e/year; Scope 2: 4.4K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
4.4K tCO2e/year (Scope 1 and 2)
2022
💧
Water Usage
616.5K tonnes/year
2022
♻️
Waste
1.1K tons/year (hazardous); 1020.98 tons/year (non-hazardous)
2022
⚙️
Energy Use
7.7K MWh/year
2022

📊 Emissions by Scope (2022)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).70.21 tCO2e/year
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.4.4K tCO2e/year

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
20224.4K tCO2e/year (Scope 1 and 2)
201942.1K tCO2e

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔜 Short-term

  • 80% reduction of hazardous waste liquid through low-temperature distillation, molecular sieve adsorption, and other processes by 2023.

🌱 ESG Focus Areas

Product quality and safetyEmployee careEnvironmental responsibilitySupply chain managementIntellectual property protectionIntegrity and honesty

⚠️ Challenges & Risks +

  • Negative impact of COVID-19 on patient visits and physician educational activities, affecting sales volume of TAVR products.
  • Challenges in enhancing the commercial profitability of TAVR procedures and promoting sustainable and quality development.
  • Impairment losses on certain intangible assets and goodwill due to the termination of business in Keystone and its subsidiaries.

📋 Report Information

Reporting Period: 2022
Frameworks: Appendix 27 of the Environmental, Social and Governance Reporting Guide (the “Guide”) of the Main Board Listing Rules of the Stock Exchange